Pfizer, Protalix submit taliglucerase MAA

Pfizer Inc. (NYSE:PFE) and partner Protalix Biotherapeutics Inc. (NYSE-A:PLX; Tel Aviv:PLX) submitted an MAA to the European Medicines Agency (EMA) for taliglucerase alfa to treat Gaucher's disease. A...